LEP and metabolic dysfunction-associated steatotic liver disease: Compared to healthy subjects, NAFLD patients demonstrated an increased leptin-stimulated TNFα and ROS production in peripheral monocytes, as well as IFNγ production in circulating CD4+ cells (a marker of Th1 differentiation) (Inzaugarat et al., 2017).